Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Mercurialis Perennis, commonly known as Dog's Mercury, is a botanical extract utilized primarily as a non-standardized allergenic extract and in specific therapeutic traditions for its potential anti-inflammatory properties.
Name
Mercurialis Perennis
Raw Name
MERCURIALIS PERENNIS
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
About Mercurialis Perennis
Mercurialis Perennis, commonly known as Dog's Mercury, is a botanical extract utilized primarily as a non-standardized allergenic extract and in specific therapeutic traditions for its potential anti-inflammatory properties.
Detailed information about Mercurialis Perennis
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Mercurialis Perennis.
Mercurialis Perennis, commonly referred to as Dog's Mercury, is a perennial herbaceous plant belonging to the Euphorbiaceae (Spurge) family. Within the clinical and pharmacological landscape, it is classified primarily as a Non-Standardized Plant Allergenic Extract [EPC]. It also appears in regulatory databases under classifications such as Standardized Chemical Allergen [EPC] and Non-Standardized Food Allergenic Extract [EPC], reflecting its diverse utility in diagnostic immunology and specialized therapeutic preparations.
In conventional medicine, Mercurialis Perennis is not typically administered as a first-line systemic pharmaceutical. Instead, it is most frequently encountered in two contexts: as an allergenic extract used by immunologists to diagnose plant-based sensitivities, and in anthroposophic or homeopathic medicine, where it is prepared in highly diluted forms for topical or mucosal application. The plant itself contains several bioactive constituents, including the alkaloid mercurialine (methylamine), saponins, and various flavonoids. Historically, while the raw plant is considered toxic to humans and livestock, processed extracts have been utilized in European traditional medicine for centuries.
The mechanism of action for Mercurialis Perennis depends heavily on its clinical application. When used as an allergenic extract, it functions by eliciting a localized IgE-mediated response (Type I hypersensitivity) when introduced to the skin. This allows healthcare providers to identify patients who may have environmental or occupational sensitivities to the plant's proteins or chemical constituents.
In therapeutic contexts, particularly in anthroposophic medicine (a system of medicine developed by Rudolf Steiner), Mercurialis Perennis is believed to modulate inflammatory processes. At a molecular level, research into the Euphorbiaceae family suggests that certain constituents may influence cytokine production or cellular adhesion molecules, though the specific molecular targets for Mercurialis Perennis remain less clearly defined than those of synthetic anti-inflammatories. In topical preparations, it is often used to support the healing of poorly granulating wounds or to treat inflammatory conditions of the eye, such as conjunctivitis (inflammation of the thin clear tissue over the white part of the eye).
Because Mercurialis Perennis is primarily used as a diagnostic extract or a topical/homeopathic preparation, traditional systemic pharmacokinetic data (absorption, distribution, metabolism, and excretion) are limited. However, clinical understanding of its constituents provides the following profile:
Mercurialis Perennis is utilized in several specific clinical scenarios:
Mercurialis Perennis is available in the following dosage forms:
> Important: Only your healthcare provider can determine if Mercurialis Perennis is right for your specific condition. This substance should never be ingested in its raw, wild form due to significant toxicity.
Dosage for Mercurialis Perennis is highly individualized and depends on the specific formulation being used.
Mercurialis Perennis has not been extensively studied in pediatric populations for conventional use.
> Note: Always consult a pediatrician before using any botanical or homeopathic product on a child.
Given the negligible systemic absorption of topical and diagnostic forms, no specific dosage adjustments are typically required for patients with kidney disease. However, caution is advised in severe renal failure if using high-frequency internal homeopathic preparations.
No dosage adjustments have been established for patients with liver impairment. The lack of CYP450 metabolism suggests a low risk of accumulation in hepatically impaired individuals.
Elderly patients may have thinner skin, which could theoretically increase the absorption of topical preparations. Healthcare providers may recommend starting with the lowest possible frequency of application.
If you miss a dose of a therapeutic preparation (like eye drops or ointment), apply it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up.
Systemic overdose from topical or homeopathic Mercurialis Perennis is extremely rare. However, accidental ingestion of the raw plant or large quantities of the extract can lead to:
In case of suspected ingestion or overdose, contact a Poison Control Center or seek emergency medical attention immediately.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
When used as a diagnostic allergenic extract, the most common side effect is a localized skin reaction at the site of testing. This is actually the intended effect for a positive test and may include:
For ophthalmic (eye) use, common side effects include:
While extremely rare for this specific ingredient, serious allergic reactions can occur, especially during diagnostic testing.
> Warning: Stop using Mercurialis Perennis and call your doctor immediately if you experience any of these:
There is limited data on the long-term use of Mercurialis Perennis. Prolonged use of ophthalmic preparations without medical supervision may mask underlying eye conditions or lead to chronic irritation from preservatives (such as benzalkonium chloride) often found in multi-dose bottles.
No FDA black box warnings have been issued for Mercurialis Perennis. It is not classified as a high-risk medication; however, its status as a non-standardized extract means that potency can vary between manufacturers, necessitating caution during diagnostic use.
Report any unusual symptoms to your healthcare provider. If you notice any side effects not listed here, contact your doctor or pharmacist.
Mercurialis Perennis must be used with caution, particularly in patients with a history of severe plant allergies. The raw plant is toxic and should never be consumed. Clinical preparations (extracts, drops, ointments) are processed to ensure safety, but they still carry risks if used improperly.
No FDA black box warnings for Mercurialis Perennis. Unlike potent systemic drugs, this botanical extract does not currently carry the highest level of FDA safety warnings.
Patients undergoing diagnostic skin testing with Mercurialis Perennis extract are at risk for systemic allergic reactions, including anaphylaxis. Testing should only be performed in facilities equipped with emergency supplies, including epinephrine (Adrenalin), antihistamines, and oxygen.
When using Mercurialis Perennis eye drops, it is vital to ensure the solution is sterile. If the solution changes color or becomes cloudy, it should be discarded. Patients should not wear contact lenses while instilling the drops unless specifically cleared by an ophthalmologist.
Patients should be warned against "natural" harvesting of Mercurialis Perennis. The plant contains mercurialine and other alkaloids that can cause severe gastrointestinal and renal distress. Only pharmaceutical-grade extracts should be used.
Mercurialis Perennis eye drops may cause temporary blurred vision. Patients should wait until their vision is completely clear before driving or operating heavy machinery. Topical skin preparations do not typically interfere with these activities.
There are no known direct interactions between alcohol and Mercurialis Perennis. However, alcohol can increase skin flushing and may exacerbate the itching associated with a positive allergy test.
There is no known withdrawal syndrome associated with Mercurialis Perennis. Patients can typically stop using topical or ophthalmic forms without tapering. However, if the condition being treated (e.g., conjunctivitis) returns or worsens after stopping, a healthcare provider should be consulted.
> Important: Discuss all your medical conditions, including any history of asthma or severe allergies, with your healthcare provider before starting Mercurialis Perennis.
There are no medications that are strictly contraindicated for use with Mercurialis Perennis due to its minimal systemic absorption. However, it should not be used simultaneously with other topical or ophthalmic products at the exact same site unless directed by a physician, as this can interfere with absorption and efficacy.
Drugs that suppress the immune system (e.g., systemic corticosteroids like prednisone, or biologics like adalimumab) may blunt the response to Mercurialis Perennis when used as a diagnostic allergenic extract. This can lead to a "false negative" result, where the patient appears not to be allergic even if they are. Healthcare providers may advise pausing these medications before testing.
While not a direct interaction, patients taking beta-blockers (e.g., metoprolol, propranolol) may be more resistant to the effects of epinephrine if an emergency allergic reaction occurs during diagnostic testing. This requires clinical vigilance.
Oral antihistamines (e.g., cetirizine, loratadine, diphenhydramine) will significantly inhibit the skin's reaction to Mercurialis Perennis extracts. These medications must typically be discontinued 3 to 7 days before allergy testing to ensure accurate results.
Applying steroid creams to the same area where Mercurialis Perennis ointment is used may alter the inflammatory response. It is best to space the application of different topical products by at least 2 hours.
There are no documented food interactions with Mercurialis Perennis. Unlike some medications, it is not affected by the consumption of grapefruit, dairy, or high-fat meals.
Mercurialis Perennis does not interfere with standard blood chemistry, hematology, or urinalysis tests. Its only "interaction" with testing is its intended use in skin prick or intradermal allergy panels.
For each major interaction, explain:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those used for allergies or asthma.
Mercurialis Perennis must NEVER be used in the following circumstances:
Conditions requiring careful risk-benefit analysis include:
Patients allergic to other members of the Spurge family (Euphorbiaceae), such as Poinsettia or the Castor Bean plant (Ricinus communis), may exhibit cross-sensitivity to Mercurialis Perennis. Caution is advised when testing or treating these individuals.
> Important: Your healthcare provider will evaluate your complete medical history, including any history of skin sensitivity or respiratory issues, before prescribing or using Mercurialis Perennis.
There are no adequate and well-controlled studies of Mercurialis Perennis in pregnant women. Animal reproduction studies have not been conducted. Because of the risk of a systemic allergic reaction (anaphylaxis) during diagnostic testing—which could lead to maternal hypotension and fetal hypoxia—skin testing is generally avoided during pregnancy. Topical or ophthalmic use of highly diluted (homeopathic) forms is often considered acceptable by anthroposophic practitioners, but conventional medical advice suggests using these only if the potential benefit justifies the potential risk to the fetus.
It is not known whether the constituents of Mercurialis Perennis are excreted in human milk. However, given the minimal systemic absorption from topical and ocular routes, the risk to a nursing infant is likely very low. As a precaution, nursing mothers should avoid applying topical ointments to the breast or nipple area to prevent direct ingestion by the infant.
Mercurialis Perennis extracts are used in pediatric allergy diagnostics under specialist supervision. In anthroposophic medicine, eye drops and ointments are used in children, but clinical data on safety and efficacy in the pediatric population are sparse compared to standard treatments. Children may be more sensitive to the irritant effects of the plant's alkaloids if the product is not properly diluted.
Clinical studies of Mercurialis Perennis did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Elderly patients with thinning skin (atrophy) should be monitored for increased localized irritation from topical forms.
Systemic toxicity involving the kidneys has been reported with ingestion of the raw plant (nephritis). However, at diagnostic or therapeutic doses of processed extracts, renal impairment does not typically require dose adjustment. Patients with end-stage renal disease (ESRD) should be monitored for any unusual systemic symptoms if using large amounts of topical preparations over long periods.
There is no evidence that hepatic impairment significantly affects the clearance of Mercurialis Perennis constituents when used topically or diagnostically. No specific dosage adjustments are recommended for patients with Child-Pugh Class A, B, or C cirrhosis.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding.
Mercurialis Perennis contains several active chemical groups. The primary alkaloid is mercurialine (methylamine), which in its raw state is a potent irritant. In diagnostic extracts, the mechanism is immunological: the plant proteins act as antigens that cross-link IgE antibodies on the surface of mast cells and basophils. This triggers the degranulation of these cells and the release of inflammatory mediators like histamine, leukotrienes, and prostaglandins, resulting in the characteristic "wheal and flare" reaction.
In therapeutic (anthroposophic) applications, the mechanism is thought to involve the modulation of local inflammatory cascades. While the exact molecular targets are not fully elucidated, some studies on related Euphorbiaceae species suggest that diterpenoids may interact with Protein Kinase C (PKC) isoforms, which play a role in cell signaling and inflammation.
| Parameter | Value |
|---|---|
| Bioavailability | <1% (Topical/Ocular) |
| Protein Binding | Not clinically significant |
| Half-life | Not established (Local action) |
| Tmax | 15-20 minutes (Diagnostic) |
| Metabolism | Amine oxidase (minor) |
| Excretion | Renal (minor metabolites) |
Mercurialis Perennis belongs to the therapeutic class of Botanical Extracts and the functional class of Allergenic Extracts. In the context of the FDA's Electronic Orange Book and NDC directory, it is often grouped with other non-standardized plant extracts used for diagnostic purposes.
Common questions about Mercurialis Perennis
Mercurialis Perennis is primarily used in two clinical areas: allergy diagnostics and complementary medicine. In allergy clinics, it serves as a non-standardized extract used in skin prick tests to identify patients with sensitivities to this specific plant. In anthroposophic medicine, it is formulated into eye drops and ointments to treat inflammatory conditions like conjunctivitis and minor skin wounds. It is valued in these traditions for its purported ability to regulate inflammatory processes. However, it is not a standard treatment for systemic diseases in conventional medicine.
The most common side effects are localized to the site of application. During an allergy test, patients typically experience a 'wheal and flare' reaction, which involves a small, itchy, raised bump and redness. When used in eye drops, some patients report a temporary stinging or burning sensation and brief blurred vision immediately after use. Topical skin application may occasionally cause mild redness or itching. Serious systemic side effects are extremely rare when using pharmaceutical-grade products.
There is no known direct interaction between alcohol and Mercurialis Perennis, especially since the drug is usually applied topically or used in very small diagnostic amounts. However, alcohol can cause blood vessels to dilate (skin flushing), which might make the itching from an allergy test or a skin condition feel more intense. It is generally best to avoid heavy alcohol consumption on the day of an allergy test to ensure the results are clear. Always follow your doctor's specific advice regarding lifestyle factors during treatment.
The safety of Mercurialis Perennis during pregnancy has not been established through rigorous clinical trials. Most healthcare providers recommend avoiding diagnostic allergy testing during pregnancy because of the small risk of a systemic reaction that could affect the mother's blood pressure and the baby's oxygen supply. While highly diluted topical or homeopathic forms are sometimes used, they should only be used under the guidance of a healthcare professional. Always weigh the benefits against the potential risks with your obstetrician.
The 'onset of action' depends on the use case. For allergy testing, the reaction is almost immediate, with results usually visible within 15 to 20 minutes. For therapeutic uses, such as treating eye irritation or skin inflammation, some relief may be felt within minutes of application. However, for chronic inflammatory conditions, it may take several days of consistent use (3-4 times daily) to see a significant improvement in symptoms. If no improvement is seen within a week, you should consult your doctor.
Yes, you can typically stop using Mercurialis Perennis suddenly without experiencing withdrawal symptoms. It is not a habit-forming substance and does not affect the body's hormonal or nervous systems in a way that requires a tapering period. However, if you are using it to treat an active condition like conjunctivitis, stopping too early may cause the symptoms to return. It is always best to complete the course of treatment recommended by your healthcare provider.
If you miss a dose of the eye drops or ointment, simply apply it as soon as you remember. If it is nearly time for your next scheduled application, skip the missed dose and continue with your regular routine. Never apply a double dose to make up for a missed one, as this may increase the risk of localized irritation. Consistency is key for therapeutic effectiveness, so try to keep your applications at evenly spaced intervals.
There is no evidence to suggest that Mercurialis Perennis causes weight gain. It is applied topically or used in diagnostic tests, meaning very little of the substance ever enters the bloodstream. It does not affect metabolism, appetite, or fluid retention, which are the typical pathways for drug-induced weight gain. If you experience unexpected weight changes while using this or any other product, you should discuss it with your healthcare provider to find the underlying cause.
Mercurialis Perennis is generally safe to use alongside other medications, but there are important exceptions for diagnostic testing. Antihistamines, for example, must be stopped several days before an allergy test because they will block the reaction. If you are using other eye drops or skin creams, you should wait at least 5 to 10 minutes between applying different products to prevent them from washing each other out. Always provide your doctor with a full list of your current medications and supplements.
Mercurialis Perennis is a botanical extract rather than a patented synthetic drug, so the concept of 'generic' vs. 'brand name' is slightly different. It is available from several different manufacturers, particularly those specializing in allergenic extracts or anthroposophic medicines (such as Weleda or Wala). While the active ingredient is the same, the concentration and inactive ingredients (like preservatives) may vary between brands. You should stick with the specific brand recommended by your specialist to ensure consistent results.